France medical device regulatory intelligence, Week 17, 2026.

Signals from 2026-04-20 to 2026-04-26, covering safety alerts, regulatory changes, device registrations, market movement, and source activity for France.

Signals
5
Sources
3
Index status
Indexable
EXECUTIVE SUMMARY

France generated 5 qualifying medical device signals during Week 17, 2026. Competitor launches led the week with 3 signals, while EUDAMED EU Device Database was the most active source. The AMYOPIC device by LABORATOIRE PRECILENS is classified as Class IIa and registered with UDI-DI 03666486000766. Withings (France) has registered two medical devices under product code DPS with the FDA.

Key observations

Competitor launches accounted for 3 of 5 qualifying signals, making it the main review lane for the week.
Regulatory changes formed the second-largest cluster, which is useful context for teams separating safety work from regulatory and market monitoring.
EUDAMED EU Device Database contributed 3 signals, so source-level follow-up should start there.
EUDAMED appeared repeatedly in the highlighted signals, which may warrant closer product, manufacturer, or competitor tracking.

Category interpretation

Competitor launches

3 competitor launches appeared in France during Week 17, 2026. Competitor-linked activity is most useful when paired with product codes, indication context, and adjacent safety signals.

Regulatory changes

1 regulatory changes appeared in France during Week 17, 2026. Regulatory-change activity should be checked against ANSM requirements, guidance, and downstream compliance workflows.

Market signals

1 market signals appeared in France during Week 17, 2026. Market signals help connect regulatory monitoring with launch planning, reimbursement, and commercial strategy.

Recommended monitoring focus

  • Check whether new France regulatory changes affect submission, labeling, vigilance, or post-market workflows.
  • Review competitor-linked signals for launch timing, market access movement, and product category momentum.
  • Use market trend signals to brief commercial, strategy, and market access teams alongside regulatory stakeholders.

Source-backed signal evidence

These source-linked items support the weekly analysis above. They are included for verification and follow-up, not as a raw feed export.

EUDAMED EU Device Database·Competitor launches·

EUDAMED: AMYOPIC by LABORATOIRE PRECILENS (Class refdata.risk-class.class-iia)

The AMYOPIC device by LABORATOIRE PRECILENS is classified as Class IIa and registered with UDI-DI 03666486000766.

Source
FDA Device Registration & Listing·Regulatory changes·

FDA Registration: Withings (France) (3013689228)

Withings (France) has registered two medical devices under product code DPS with the FDA.

Source
Fierce Biotech·Market signals·

Kurma closes €215M Europe-focused fund to spread across 20 biotechs

Kurma Partners raised €215M for its fourth biotech fund to support 20 European startups.

Source
EUDAMED EU Device Database·Competitor launches·

EUDAMED: Attelle de Poignet Long GL Gauche Moyen by MEDISPORT (Class refdata.risk-class.class-i)

MEDISPORT's Long Wrist Brace GL Left Medium is a Class I medical device with UDI-DI 03664617008919.

Source
EUDAMED EU Device Database·Competitor launches·

EUDAMED: SOLOJEKT by I'M Medicare SARL (Class refdata.risk-class.class-iia)

The SOLOJEKT device by I'M Medicare SARL is classified as Class IIa and registered with UDI-DI 06118002222390.

Source

Competitor launches

EUDAMED EU Device Database·Competitor launches·

EUDAMED: AMYOPIC by LABORATOIRE PRECILENS (Class refdata.risk-class.class-iia)

The AMYOPIC device by LABORATOIRE PRECILENS is classified as Class IIa and registered with UDI-DI 03666486000766.

Source
EUDAMED EU Device Database·Competitor launches·

EUDAMED: Attelle de Poignet Long GL Gauche Moyen by MEDISPORT (Class refdata.risk-class.class-i)

MEDISPORT's Long Wrist Brace GL Left Medium is a Class I medical device with UDI-DI 03664617008919.

Source
EUDAMED EU Device Database·Competitor launches·

EUDAMED: SOLOJEKT by I'M Medicare SARL (Class refdata.risk-class.class-iia)

The SOLOJEKT device by I'M Medicare SARL is classified as Class IIa and registered with UDI-DI 06118002222390.

Source

Regulatory changes

FDA Device Registration & Listing·Regulatory changes·

FDA Registration: Withings (France) (3013689228)

Withings (France) has registered two medical devices under product code DPS with the FDA.

Source

Market signals

Fierce Biotech·Market signals·

Kurma closes €215M Europe-focused fund to spread across 20 biotechs

Kurma Partners raised €215M for its fourth biotech fund to support 20 European startups.

Source

Track these signals continuously.

MedFlux monitors regulators and medical device market sources across priority countries so regulatory, quality, and strategy teams can review changes without manually checking agency databases.

Related MedFlux intelligence pages